Christie M. Ballantyne
0000-0002-6432-1730
Publication & Citation Trends
Publications
0 total
Obicetrapib in patients with heterozygous familial hypercholesterolemia: the BROOKLYN randomized clinical trial.
Cited by 0
Semantic Scholar
Oral PCSK9 Inhibitor Enlicitide versus Oral Non-statin Therapies: A Phase 3 Randomized Clinical Trial
Cited by 0
Semantic Scholar
Rethinking “Very High-Risk” ASCVD
Cited by 0
Semantic Scholar
Benefit of Icosapent Ethyl Across Types and Sizes of Myocardial Infarction in REDUCE-IT.
Cited by 1
Semantic Scholar
Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis.
Cited by 18
Semantic Scholar
Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis.
Cited by 12
Semantic Scholar
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications.
Cited by 2
Semantic Scholar
Simulation model to estimate pretreatment (baseline) low-density lipoprotein cholesterol levels in people living with homozygous familial hypercholesterolemia.
Cited by 2
Semantic Scholar
Research Topics
Lipoproteins and Cardiovascular Health
(738)
Diabetes, Cardiovascular Risks, and Lipoproteins
(348)
Cancer, Lipids, and Metabolism
(188)
Cardiovascular Health and Risk Factors
(165)
Health Systems, Economic Evaluations, Quality of Life
(151)
Affiliations
Université du Québec à Chicoutimi
AstraZeneca (United Kingdom)
Broad Institute
American College of Cardiology
Boston University